EGFR mutation in lung cancer: tumor heterogeneity and the impact of chemotherapy`

被引：5

作者：

Bar, Jair ^{[1
]}

Urban, Damien ^{[2
]}

Borshtein, Roni ^{[1
]}

Nechushtan, Hovav ^{[3
]}

Onn, Amir ^{[1
]}

机构：

[1] Sheba Med Ctr, Oncol Inst, Ramat Gan, Israel

[2] Peter MacCallum Canc Ctr, Dept Med, Melbourne, Vic, Australia

[3] Hadassah Hebrew Univ Med Ctr, Sharett Inst Oncol, Jerusalem, Israel

来源：

CHINESE CLINICAL ONCOLOGY | 2013年 / 2卷 / 01期

关键词：

D O I：

10.3978/j.issn.2304-3865.2012.12.03

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 18 条

[1] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer [J].

Bai, Hua ;

Wang, Zhijie ;

Chen, Keneng ;

Zhao, Jun ;

Lee, J. Jack ;

Wang, Shuhang ;

Zhou, Qinghua ;

Zhuo, Minglei ;

Mao, Li ;

An, Tongtong ;

Duan, Jianchun ;

Yang, Lu ;

Wu, Meina ;

Liang, Zhen ;

Wang, Yuyan ;

Kang, Xiaozheng ;

Wang, Jie .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3077-3083

[2] Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non-Small-Cell Lung Cancer [J].

Bai, Hua ;

Mao, Li ;

Wang, Hang Shu ;

Zhao, Jun ;

Yang, Lu ;

An, Tong Tong ;

Wang, Xin ;

Duan, Chun Jian ;

Wu, Na Mei ;

Guo, Zhi Qing ;

Liu, Yi Xu ;

Liu, Hong Ning ;

Wang, Ye Yu ;

Wang, Jie .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) :2653-2659

[3] Overcoming Molecular Mechanisms of Resistance to First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [J].

Bar, Jair ;

Onn, Amir .

CLINICAL LUNG CANCER, 2012, 13 (04) :267-279

[4] Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study [J].

Cappuzzo, Federico ;

Ciuleanu, Tudor ;

Stelmakh, Lilia ;

Cicenas, Saulius ;

Szczesna, Aleksandra ;

Juhasz, Erzsebet ;

Esteban, Emilio ;

Molinier, Olivier ;

Brugger, Wolfram ;

Melezinek, Ivan ;

Klingelschmitt, Gaelle ;

Klughammer, Barbara ;

Giaccone, Giuseppe .

LANCET ONCOLOGY, 2010, 11 (06) :521-529

[5] EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas [J].

Chen, Zhi-Yong ;

Zhong, Wen-Zhao ;

Zhang, Xu-Chao ;

Su, Jian ;

Yang, Xue-Ning ;

Chen, Zhi-Hong ;

Yang, Jin-Ji ;

Zhou, Qing ;

Yan, Hong-Hong ;

An, She-Juan ;

Chen, Hua-Jun ;

Jiang, Ben-Yuan ;

Mok, Tony S. ;

Wu, Yi-Long .

ONCOLOGIST, 2012, 17 (07) :978-985

[6] Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial [J].

Douillard, Jean-Yves ;

Shepherd, Frances A. ;

Hirsh, Vera ;

Mok, Tony ;

Socinski, Mark A. ;

Gervais, Radj ;

Liao, Mei-Lin ;

Bischoff, Helge ;

Reck, Martin ;

Sellers, Mark V. ;

Watkins, Claire L. ;

Speake, Georgina ;

Armour, Alison A. ;

Kim, Edward S. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) :744-752

[7] Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS) [J].

Fukuoka, Masahiro ;

Wu, Yi-Long ;

Thongprasert, Sumitra ;

Sunpaweravong, Patrapim ;

Leong, Swan-Swan ;

Sriuranpong, Virote ;

Chao, Tsu-Yi ;

Nakagawa, Kazuhiko ;

Chu, Da-Tong ;

Saijo, Nagahiro ;

Duffield, Emma L. ;

Rukazenkov, Yuri ;

Speake, Georgina ;

Jiang, Haiyi ;

Armour, Alison A. ;

To, Ka-Fai ;

Yang, James Chih-Hsin ;

Mok, Tony S. K. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) :2866-2874

[8] Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [J].

Gerlinger, Marco ;

Rowan, Andrew J. ;

Horswell, Stuart ;

Larkin, James ;

Endesfelder, David ;

Gronroos, Eva ;

Martinez, Pierre ;

Matthews, Nicholas ;

Stewart, Aengus ;

Tarpey, Patrick ;

Varela, Ignacio ;

Phillimore, Benjamin ;

Begum, Sharmin ;

McDonald, Neil Q. ;

Butler, Adam ;

Jones, David ;

Raine, Keiran ;

Latimer, Calli ;

Santos, Claudio R. ;

Nohadani, Mahrokh ;

Eklund, Aron C. ;

Spencer-Dene, Bradley ;

Clark, Graham ;

Pickering, Lisa ;

Stamp, Gordon ;

Gore, Martin ;

Szallasi, Zoltan ;

Downward, Julian ;

Futreal, P. Andrew ;

Swanton, Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :883-892

[9] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[10] Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR. [J].

Maemondo, Makoto ;

Inoue, Akira ;

Kobayashi, Kunihiko ;

Sugawara, Shunichi ;

Oizumi, Satoshi ;

Isobe, Hiroshi ;

Gemma, Akihiko ;

Harada, Masao ;

Yoshizawa, Hirohisa ;

Kinoshita, Ichiro ;

Fujita, Yuka ;

Okinaga, Shoji ;

Hirano, Haruto ;

Yoshimori, Kozo ;

Harada, Toshiyuki ;

Ogura, Takashi ;

Ando, Masahiro ;

Miyazawa, Hitoshi ;

Tanaka, Tomoaki ;

Saijo, Yasuo ;

Hagiwara, Koichi ;

Morita, Satoshi ;

Nukiwa, Toshihiro .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25) :2380-2388

← 1 2 →